Literature DB >> 33443669

The predictive value of platelet to lymphocyte ratio and D-dimer to fibrinogen ratio combined with WELLS score on lower extremity deep vein thrombosis in young patients with cerebral hemorrhage.

Huijun Wen1, Yingcong Chen2.   

Abstract

OBJECTIVE: To study the predictive effect on YCH patients complicated with LEDVT by PLR and DFR combined with WELLS score.
MATERIALS AND METHODS: A total of 109 patients with YCH were selected as the research subjects. Patients with combined LEDVT were in the thrombosis group (33 cases), and without LEDVT in the non-thrombosis group (76 cases). Wells score was used to evaluate the vascular of the lower extremities. The PLR and DFR were calculated. The diagnostic value of PLR and DFR combined with the Wells score was evaluated by the AUC, sensitivity, specificity, and other indicators in the ROC.
RESULTS: The values of PLR, DFR, and Wells score in the thrombus group were 149.20 ± 52.17, 118.46 ± 8.37, and 2.67 ± 0.48, and that of the non-thrombotic group were 95.27 ± 29.48, 75.28 ± 10.16, and 0.72 ± 0.34, respectively. The differences were statistically significant. ROC results showed good diagnosis power of PLR (sensitivity 86.35%, specificity 75.18%, AUC 0.702.), DFR (sensitivity 88.57%, specificity 79.21%, AUC 0.786.), and the Wells score (sensitivity 90.17%, specificity 81.06%, AUC 0.889.). The combined application of the Wells score, PLR, and DFR for the occurrence of LEDVT had a sensitivity of 97.65%, a specificity of 92.43%, a missed diagnosis rate of 2.35%, and a misdiagnosis rate of 7.57%. The area under the ROC curve was 0.951, which was higher than using these variables independently.
CONCLUSIONS: PLR and DFR combined with Wells score have high specificity for predicting LEDVT in YCH patients with low missed diagnosis and low misdiagnosis rates. They are worthy of popularization and application.

Entities:  

Keywords:  Cerebral hemorrhage; D-dimer to fibrinogen ratio (DFR); Lower extremity deep vein thrombosis; Platelet to lymphocyte ratio (PLR); Youth

Year:  2021        PMID: 33443669     DOI: 10.1007/s10072-020-05007-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  16 in total

1.  Usefulness of the D-dimer/fibrinogen ratio to predict deep venous thrombosis.

Authors:  W A Wuillemin; W Korte; G Waser; B Lämmle
Journal:  J Thromb Haemost       Date:  2005-02       Impact factor: 5.824

2.  Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo
Journal:  Stroke       Date:  2010-07-22       Impact factor: 7.914

3.  Determining the magnitude of surveillance bias in the assessment of lower extremity deep venous thrombosis: A prospective observational study of two centers.

Authors:  Steven R Shackford; Mark D Cipolle; Jayraan Badiee; Danielle L Mosby; M Margaret Knudson; Paul R Lewis; Victoria S McDonald; Erik J Olson; Kimberly A Thompson; Jan-Michael Van Gent; Ashley L Zander
Journal:  J Trauma Acute Care Surg       Date:  2016-05       Impact factor: 3.313

Review 4.  Diagnosis and management of clinical chorioamnionitis.

Authors:  Alan T N Tita; William W Andrews
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

5.  The Potential Value of D-Dimer to Fibrinogen Ratio in Diagnosis of Acute Ischemic Stroke.

Authors:  Xing Chen; Sijin Li; Wei Chen; Fei Xu; Yan Wang; Guoying Zou; Biqiong Ren
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-05-16       Impact factor: 2.136

6.  Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke.

Authors:  F J Alvarez-Perez; M Castelo-Branco; J Alvarez-Sabin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-02-04       Impact factor: 10.154

7.  Is prophylactic anticoagulation for deep venous thrombosis common practice after intracerebral hemorrhage?

Authors:  Shyam Prabhakaran; Patricia Herbers; Jane Khoury; Opeolu Adeoye; Pooja Khatri; Simona Ferioli; Dawn O Kleindorfer
Journal:  Stroke       Date:  2015-01-08       Impact factor: 7.914

Review 8.  Deep vein thrombosis: pathogenesis, diagnosis, and medical management.

Authors:  Jonathan Stone; Patrick Hangge; Hassan Albadawi; Alex Wallace; Fadi Shamoun; M Grace Knuttien; Sailendra Naidu; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 9.  Cancer and venous thromboembolism: prevention, treatment and survival.

Authors:  Agnes Yuet Ying Lee
Journal:  J Thromb Thrombolysis       Date:  2007-09-29       Impact factor: 2.300

10.  Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease.

Authors:  Elbis Ahbap; Tamer Sakaci; Ekrem Kara; Tuncay Sahutoglu; Yener Koc; Taner Basturk; Mustafa Sevinc; Cuneyt Akgol; Arzu O Kayalar; Zuhal A Ucar; Feyza Bayraktar; Abdulkadir Unsal
Journal:  Clin Nephrol       Date:  2016-04       Impact factor: 0.975

View more
  2 in total

1.  Prediction of Early Mortality Among Children With Moderate or Severe Traumatic Brain Injury Based on a Nomogram Integrating Radiological and Inflammation-Based Biomarkers.

Authors:  Pingyi Zhu; Nimo Mohamed Hussein; Jing Tang; Lulu Lin; Yu Wang; Lan Li; Kun Shu; Pinfa Zou; Yikai Xia; Guanghui Bai; Zhihan Yan; Xinjian Ye
Journal:  Front Neurol       Date:  2022-05-20       Impact factor: 4.086

2.  Leukocyte as an Independent Predictor of Lower-Extremity Deep Venous Thrombosis in Elderly Patients With Primary Intracerebral Hemorrhage.

Authors:  Gang Wang; Wenjun Zhao; Zhiyong Zhao; Dengfeng Wang; Dong Wang; Ruobing Bai; Boru Hou; Haijun Ren
Journal:  Front Neurol       Date:  2022-07-12       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.